HHS Secretary RFK Jr. just dropped major news: the FDA is removing 12 peptides from its restrictive Category 2 list reversing the 2023 crackdown that shut down compounding pharmacies and fueled An important update for anyone following the peptide space. While these compounds are still under evaluation and not FDA approved, this shift signals growing momentum toward clinician guided peptide research. Stay informed, stay A Note on Peptides by Shantanu Out of Singapore 2026 FDA Peptide Reclassification Purefico Medspa and Therapy FDA Peptide Reclassification 2026: What Researchers Want